Pharmaceuticals Inc Ionis serves as Executive at AKCEA THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Pharmaceuticals Inc Ionis has executed 10 insider transactions totaling $610.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 10, 2020 involved purchasing 21,237,715 shares valued at $385.5M.
Pharmaceuticals Inc Ionis currently holds 98,322,397 shares of AKCEA THERAPEUTICS, INC. (AKCA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pharmaceuticals Inc Ionis has been a net buyer of AKCA stock. They have purchased $610.5M and sold $0 worth of shares.
Pharmaceuticals Inc Ionis's most recent insider trade was on Oct 10, 2020, when they purchased 21,237,715 shares at $18.15 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 29, 2019 | AKCA | $0 | Other | 2,837,373 | $N/A | Discretionary |
| Oct 17, 2018 | AKCA | $0 | Other | 1,671,849 | $N/A | Discretionary |
| Aug 3, 2018 | AKCA | $0 | Other | 1,597,571 | $N/A | Discretionary |
| Apr 17, 2018 | AKCA | $200.0M | Purchase | 10,666,666 | $18.75 | Discretionary |
| Apr 17, 2018 | AKCA | $0 | Other | 8,000,000 | $N/A | Discretionary |
| Jul 19, 2017 | AKCA | $0 | Conversion | 28,884,540 | $N/A | Discretionary |
| Jul 19, 2017 | AKCA | $0 | Other | 13,438,339 | $N/A | Discretionary |
| Jul 19, 2017 | AKCA | $25.0M | Purchase | 3,125,000 | $8.00 | Discretionary |